Given the modest reductions in such CV risk factors as BP and weight, what might be the mechanistic effects that explain the significant reduction in CV outcomes observed in LEADER?

Given the modest reductions in such CV risk factors as BP and weight, what might be the mechanistic effects that explain the significant reduction in CV outcomes observed in LEADER?

Given the rather modest reductions in such CV risk factors as BP and weight, what do you believe might be the mechanistic or physiologic effects that explain the significant reduction in CV outcomes observed in LEADER?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Luc Van Gaal, MD

Luc Van Gaal, MD

Professor of Medicine
Department of Endocrinology, Diabetology and Metabolism
Antwerp University Hospital
Antwerp, Belgium